Home > > > Report Detail

Global (United States, European Union and China) Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Research Report 2019-2025

Publisher Name :
Date: 09-Aug-2019
No. of pages: 116
Inquire Before Buying

DTaP (also DTPa and TDaP) is a combined vaccine against diphtheria, tetanus, and pertussis, in which the pertussis component is acellular. This is in contrast to whole-cell, inactivated DTP (aka DTwP). The acellular vaccine uses selected antigens of the pertussis pathogen to induce immunity. Because it uses fewer antigens than the whole cell vaccines, it is considered safer, but it is also more expensive. Recent research suggests that the DTP vaccine is more effective than DTaP in conferring immunity; this is because DTaP's narrower antigen base is less effective against current pathogen strains.

In 2019, the market size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine.

This report studies the global market size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

- Sanofi Pasteur

- GlaxoSmithKline

- Protein Sciences Corporation

- Novartis AG

- Seqirus

- Merck Sharp & Dohme Corp

- Astellas Pharma US, Inc

- Pfizer Inc

- Johnson & Johnson

- Lanzhou Institute of Biological Products Co., Ltd

- AstraZeneca

- Emergent BioSolutions Inc

Market Segment by Product Type

- Immune DTaP Vaccine

- Therapy DTaP Vaccine

Market Segment by Application

- Adult

- Pediatric

Key Regions split in this report: breakdown data for each region.

- United States

- China

- European Union

- Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

- To analyze and research the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

- To present the key Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.

- To split the breakdown data by regions, type, companies and applications

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends, drivers, influence factors in global and regions

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

Global (United States, European Union and China) Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Growth Rate by Type (2019-2025)
1.3.2 Immune DTaP Vaccine
1.3.3 Therapy DTaP Vaccine
1.4 Market Segment by Application
1.4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application (2019-2025)
1.4.2 Adult
1.4.3 Pediatric
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size
2.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue 2014-2025
2.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales 2014-2025
2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Growth Rate by Regions
2.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Regions 2014-2019
2.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers
3.1.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers 2014-2019
3.1.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Manufacturers
3.4 Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market
3.6 Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Immune DTaP Vaccine Sales and Revenue (2014-2019)
4.1.2 Therapy DTaP Vaccine Sales and Revenue (2014-2019)
4.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type
4.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Type
4.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application
6 United States
6.1 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Company
6.2 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Type
6.3 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Application
7 European Union
7.1 European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Company
7.2 European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Type
7.3 European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Application
8 China
8.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Company
8.2 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Type
8.3 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Application
9 Rest of World
9.1 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Company
9.2 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Type
9.3 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Application
9.4 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Countries
9.4.1 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries
9.4.2 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Sanofi Pasteur
10.1.1 Sanofi Pasteur Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.1.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.1.5 Sanofi Pasteur Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.2.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.2.5 GlaxoSmithKline Recent Development
10.3 Protein Sciences Corporation
10.3.1 Protein Sciences Corporation Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.3.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.3.5 Protein Sciences Corporation Recent Development
10.4 Novartis AG
10.4.1 Novartis AG Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.4.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.4.5 Novartis AG Recent Development
10.5 Seqirus
10.5.1 Seqirus Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.5.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.5.5 Seqirus Recent Development
10.6 Merck Sharp & Dohme Corp
10.6.1 Merck Sharp & Dohme Corp Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.6.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.6.5 Merck Sharp & Dohme Corp Recent Development
10.7 Astellas Pharma US, Inc
10.7.1 Astellas Pharma US, Inc Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.7.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.7.5 Astellas Pharma US, Inc Recent Development
10.8 Pfizer Inc
10.8.1 Pfizer Inc Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.8.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.8.5 Pfizer Inc Recent Development
10.9 Johnson & Johnson
10.9.1 Johnson & Johnson Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.9.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.9.5 Johnson & Johnson Recent Development
10.10 Lanzhou Institute of Biological Products Co., Ltd
10.10.1 Lanzhou Institute of Biological Products Co., Ltd Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
10.10.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
10.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Development
10.11 AstraZeneca
10.12 Emergent BioSolutions Inc
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Channels
11.2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors
11.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers
12 Market Forecast
12.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue Forecast 2019-2025
12.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Type
12.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Application
12.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast by Regions
12.4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Regions 2019-2025
12.4.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Picture
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Key Market Segments
Table Major Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Covered in This Report
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Growth Rate by Type 2019-2025 (K Doses) & (Million US$)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Shar by Type 2014-2025
Figure Immune DTaP Vaccine Figures
Table Major Manufacturers of Immune DTaP Vaccine
Figure Therapy DTaP Vaccine Figures
Table Major Manufacturers of Therapy DTaP Vaccine
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application 2019-2025 (K Doses)
Figure Adult Use Case
Figure Pediatric Use Case
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Report Years Considered
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size 2014-2025 (Million US$)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales 2014-2019 (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Regions 2014-2019 (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Regions 2014-2019
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Regions 2014-2019
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Regions in 2019
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers (2014-2019) (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Manufacturers in 2019
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Value Share by Manufacturers in 2019
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (2014-2019) (USD/Dose)
Table Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Plants/Factories Distribution
Table Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Area Served
Table Date of Key Manufacturers Enter into Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market
Table Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Immune DTaP Vaccine Sales and Revenue (2014-2019) (K Doses) & (Million US$)
Table Global Therapy DTaP Vaccine Sales and Revenue (2014-2019) (K Doses) & (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2014-2019) (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Type (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type in 2018
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Type (2014-2019) (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Type (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Type (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Type in 2018
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Type 2014-2019 (USD/Dose)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2014-2019) (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Application (2014-2019)
Figure Global Sales Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application (2014-2019)
Figure Global Sales Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application (2014-2019)
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Company (2014-2019) (K Doses)
Table United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company (2014-2019)
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company in 2019
Table United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2014-2019) (K Doses)
Table United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2014-2019)
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Type in 2019
Table United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2014-2019) (K Doses)
Table United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application (2014-2019)
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application in 2019
Figure European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Company (2014-2019) (K Doses)
Table European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company (2014-2019)
Figure European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company in 2019
Table European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2014-2019) (K Doses)
Table European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2014-2019)
Figure 2018 European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Type
Table European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2014-2019) (K Doses)
Table European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application (2014-2019)
Figure 2018 European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Company (2014-2019) (K Doses)
Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company (2014-2019)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company in 2019
Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2014-2019) (K Doses)
Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2014-2019)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Type in 2019
Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2014-2019) (K Doses)
Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application (2014-2019)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application in 2019
Figure Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Company (2014-2019) (K Doses)
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company (2014-2019)
Figure Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Company in 2019
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2014-2019) (K Doses)
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2014-2019)
Figure Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Type in 2019
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2014-2019) (K Doses)
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application (2014-2019)
Figure Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application in 2019
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries (2014-2019) (K Doses)
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries (2014-2019)
Figure Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries in 2019
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries (2014-2019)
Figure Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries in 2019
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Description and Business Overview
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Sanofi Pasteur Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Table Protein Sciences Corporation Company Details
Table Protein Sciences Corporation Description and Business Overview
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Protein Sciences Corporation Recent Development
Table Novartis AG Company Details
Table Novartis AG Description and Business Overview
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Novartis AG Recent Development
Table Seqirus Company Details
Table Seqirus Description and Business Overview
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Seqirus Recent Development
Table Merck Sharp & Dohme Corp Company Details
Table Merck Sharp & Dohme Corp Description and Business Overview
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Merck Sharp & Dohme Corp Recent Development
Table Astellas Pharma US, Inc Company Details
Table Astellas Pharma US, Inc Description and Business Overview
Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Astellas Pharma US, Inc Recent Development
Table Pfizer Inc Company Details
Table Pfizer Inc Description and Business Overview
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Pfizer Inc Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Description and Business Overview
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Johnson & Johnson Recent Development
Table Lanzhou Institute of Biological Products Co., Ltd Company Details
Table Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
Table Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2014-2019)
Table Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Global Market
Table Lanzhou Institute of Biological Products Co., Ltd Recent Development
Table AstraZeneca Company Details
Table Emergent BioSolutions Inc Company Details
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Value Chain
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors List
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers List
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses) & (Million US$)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast 2019-2025 (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Type 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Type 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share Forecast by Type 2019-2025
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Application 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Application 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share Forecast by Application 2019-2025
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Regions 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Regions 2019-2025 (K Doses)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share Forecast by Regions 2019-2025
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses)
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses)
Figure European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs